Dexamethasone and COVID-19 appears to support your hypothesis,...

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    Dexamethasone and COVID-19 appears to support your hypothesis, but I noticed this bit:

    For hospitalised patients with COVID-19 who were well enough to breathe on their own, dexamethasone offered no benefit; in fact there is a possibility that the medicine could have worsened health outcomes for some of those patients.

    Patients in NOXCOVID-1 will be able to breathe on their own, so it looks like the experts who designed the trial are familiar with dexa and have factored its moa into the trial design.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
5.0¢
Change
0.001(2.04%)
Mkt cap ! $14.61M
Open High Low Value Volume
5.0¢ 5.1¢ 5.0¢ $14.75K 295K

Buyers (Bids)

No. Vol. Price($)
1 763 5.0¢
 

Sellers (Offers)

Price($) Vol. No.
5.1¢ 49807 1
View Market Depth
Last trade - 16.10pm 04/07/2025 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.